Skip to main content

Closed

BCDA: BioCardia, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC1195.4%

Financially safe

Stretched

Debt / equity-0.39×

Interest coverage0.0×

Current ratio0.41×

BioCardia, Inc.

BCDANASDAQ Capital Market·USD·Closed

BioCardia, Inc.

BCDANASDAQ·USD·Closed

$0.82

+6.89%

$0.82

+$0.05 (6.89%)

52W Range

5thpctl

Volume

0.04×avg

Mkt Cap

4.78MUSD

P/E

-0.9TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.04×avg

Market Cap

4.78MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings